about
Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future Directions.The role of 90Y-radioembolization in downstaging primary and secondary hepatic malignancies: a systematic reviewMagnetic resonance imaging of the cirrhotic liver in the era of gadoxetic acid25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future PerspectivesRecent Advances in Tumor Ablation for Hepatocellular CarcinomaThe role of gadoxetic acid as a paramagnetic contrast medium in the characterization and detection of focal liver lesions: a reviewTumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCCDiagnosis of Pathologically Early HCC with EOB-MRI: Experiences and Current ConsensusRecent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRILiver fibrosis and Gd-EOB-DTPA-enhanced MRI: A histopathologic correlationRole of (drug) transporters in imaging in health and disease.Investigations on the Ga(III) Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue.Quantitative Measurement of Hepatic Fibrosis with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Chronic Hepatitis B Infection: A Comparative Study on Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index.Histogram analysis of gadoxetic acid-enhanced MRI for quantitative hepatic fibrosis measurementCholangiocarcinoma: spectrum of appearances on Gd-EOB-DTPA-enhanced MR imaging and the effect of biliary function on signal intensityThe inhomogeneous distribution of liver function: possible impact on the prediction of post-operative remnant liver function.Gd-EOB-DTPA-enhanced magnetic resonance imaging for bile duct intraductal papillary mucinous neoplasms.Combined Application of Gadoxetic Acid Disodium-Enhanced Magnetic Resonance Imaging (MRI) and Diffusion-Weighted Imaging (DWI) in the Diagnosis of Chronic Liver Disease-Induced Hepatocellular Carcinoma: A Meta-Analysis.Gadoxetic acid-enhanced MRI for the characterization of hepatocellular carcinoma: A systematic review and meta-analysis.Prognostic Significance of Concurrent Hypovascular and Hypervascular Nodules in Patients with Hepatocellular Carcinoma.Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents.Gd-EOB-DTPA-Enhanced MRI for Detection of Liver Metastases from Colorectal Cancer: A Surgeon's Perspective!Use of gadoxetate disodium for functional MRI based on its unique molecular mechanism.MRI-based assessment of liver perfusion and hepatocyte injury in the murine model of acute hepatitis.The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase.Quantitative Assessment of Liver Function Using Gadoxetate-Enhanced Magnetic Resonance Imaging: Monitoring Transporter-Mediated Processes in Healthy Volunteers.Organic anion-transporting polypeptides.Assessment of hepatic function with Gd-EOB-DTPA-enhanced hepatic MRI.P4 radiology of hepatobiliary diseases with gadoxetic acid-enhanced MRI as a biomarker.The role of bridging therapy in hepatocellular carcinoma.Recent advances in estimating hepatic functional reserve in patients with chronic liver damage.Consensus report from the 6th International forum for liver MRI using gadoxetic acid.Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma.Gadoxetic acid: pearls and pitfalls.Visual assessment of biliary excretion of Gd-EOB-DTPA in patients with suspected diffuse liver disease - A biopsy-verified prospective study.Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment.Gd-EOB-DTPA-Enhanced Magnetic Resonance Findings of a Giant Inflammatory Hepatocellular Adenoma: a Case Report and Review of the Literature.Evaluation of biliary ductal anatomy in potential living liver donors: comparison between MRCP and Gd-EOB-DTPA-enhanced MRI.Magnetic resonance imaging of the cirrhotic liver: diagnosis of hepatocellular carcinoma and evaluation of response to treatment - Part 2.
P2860
Q26738871-AFA5D2E0-6DBF-47D4-A77C-599A1A66AF88Q26741882-9C256296-76EF-47E7-A0F9-BDACE8DAFE1DQ26769602-BD33CED3-4521-48BF-84F2-BC92AFD9CF21Q26774810-8CD11612-F0CB-4691-BADA-3980F2DD912EQ26775418-C6EF7BCB-636D-4CC5-919A-2F7CBAC4CAB3Q26828543-EBBD39DF-6E5F-4123-AE92-24C87F13FA84Q27011253-9CABA99B-EBF5-4BA0-B9A4-4CF2F466D940Q27027855-2400B2DC-E06C-4FBE-AC7F-0284C2759A3BQ28075361-0CE3124B-0EB1-4695-96DF-A6343F78A2C4Q30359290-1AB40AB6-530D-471A-837A-DA5666FFCF84Q30854787-55224E35-7B91-4602-835B-34AF3A2CEBD8Q31126059-193873B3-5E6D-4045-9917-561CE480593DQ33561380-3937FDD4-4D70-44A3-AA6A-2C703673933BQ34612486-DC98C07A-FFAC-4257-98A2-03B3CDC4CF92Q35072802-027191EB-6A2C-4743-A3E4-5183ABCF41DFQ35099283-2183BBF2-FA07-406B-B9AC-4F1DA1E2EEEFQ35819568-6184910D-F084-42C7-AC30-82448B513B5DQ35858656-5E1300B6-7D4A-44EA-9AEC-96943E3B9E85Q36051492-0E5C3720-D161-4D4F-9F97-FDDF1D74DF44Q36138282-60A7FDB2-D0F3-468C-8F6B-88EE097808BEQ36437195-B1CB206D-FA92-4449-A4E7-F3788657EDA2Q36651282-0040B896-BBB4-4775-819E-6BDC36317D9DQ36802087-FD8057E5-5E9A-4C96-9944-5BA612F58689Q37175669-490DD2AF-92BB-496F-AA16-70CA2DD0810EQ37442224-AA220096-8F9B-4169-9A84-C949E7CA30EDQ37488806-1E4B5A38-0AFD-48B3-A74B-33F8D996A494Q37582508-69F53106-6666-49A0-97EA-2C187F9AB1B5Q37718185-AD2A7C1B-2261-4EFC-9D66-5B653BA415EDQ38069066-A0B6454E-1D4C-4927-8BE6-B313F4A0B3FBQ38177850-A00091FC-C506-4B39-AEA7-A994F2A44AD4Q38181127-019DD296-A867-4530-821A-4ADC83EE6F3BQ38194202-ED41608E-7453-48C5-B345-9E59CB755F02Q38219801-B8D8DEF7-BADA-414F-ABAE-DE9CFBA3CCEBQ38238010-5AF2DE67-A5EB-4129-B287-3F4876C25D6FQ38329089-69E48B14-2CA9-420A-912D-B5A542D48F79Q38367219-1676A085-9848-4531-88CE-28391B2616E0Q38412364-0C0332A2-57E8-426B-B8F0-E45D4CF8CA58Q38430622-94179FC6-2E2A-4F02-9B16-7DD8475E737FQ38803012-47589F3A-0FEC-4932-9464-BAF51014E15EQ38827648-8043D35D-373D-461E-9792-1D1F9C3F3CB1
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Primovist, Eovist: what to expect?
@en
type
label
Primovist, Eovist: what to expect?
@en
prefLabel
Primovist, Eovist: what to expect?
@en
P1476
Primovist, Eovist: what to expect?
@en
P2093
Hero K Hussain
P304
P356
10.1016/J.JHEP.2012.01.031
P577
2012-04-12T00:00:00Z